chr8-56441508-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001135690.3(PENK):āc.568A>Gā(p.Met190Val) variant causes a missense change. The variant allele was found at a frequency of 0.000695 in 1,613,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00055 ( 0 hom., cov: 32)
Exomes š: 0.00071 ( 0 hom. )
Consequence
PENK
NM_001135690.3 missense
NM_001135690.3 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
PENK (HGNC:8831): (proenkephalin) This gene encodes a preproprotein that is proteolytically processed to generate multiple protein products. These products include the pentapeptide opioids Met-enkephalin and Leu-enkephalin, which are stored in synaptic vesicles, then released into the synapse where they bind to mu- and delta-opioid receptors to modulate the perception of pain. Other non-opioid cleavage products may function in distinct biological activities. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2820953).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PENK | NM_001135690.3 | c.568A>G | p.Met190Val | missense_variant | 4/4 | ENST00000451791.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PENK | ENST00000451791.7 | c.568A>G | p.Met190Val | missense_variant | 4/4 | 1 | NM_001135690.3 | P1 | |
PENK | ENST00000314922.3 | c.568A>G | p.Met190Val | missense_variant | 2/2 | 1 | P1 | ||
PENK | ENST00000517415.1 | c.129+4308A>G | intron_variant | 3 | |||||
PENK | ENST00000523274.1 | n.490A>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000553 AC: 84AN: 151986Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
84
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000426 AC: 107AN: 251378Hom.: 1 AF XY: 0.000420 AC XY: 57AN XY: 135868
GnomAD3 exomes
AF:
AC:
107
AN:
251378
Hom.:
AF XY:
AC XY:
57
AN XY:
135868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000710 AC: 1037AN: 1461558Hom.: 0 Cov.: 33 AF XY: 0.000671 AC XY: 488AN XY: 727122
GnomAD4 exome
AF:
AC:
1037
AN:
1461558
Hom.:
Cov.:
33
AF XY:
AC XY:
488
AN XY:
727122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000552 AC: 84AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.000538 AC XY: 40AN XY: 74384
GnomAD4 genome
AF:
AC:
84
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
40
AN XY:
74384
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
7
ExAC
AF:
AC:
47
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.568A>G (p.M190V) alteration is located in exon 2 (coding exon 2) of the PENK gene. This alteration results from a A to G substitution at nucleotide position 568, causing the methionine (M) at amino acid position 190 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at